364 related articles for article (PubMed ID: 27103465)
1. microRNA-206 is involved in survival of hypoxia preconditioned mesenchymal stem cells through targeting Pim-1 kinase.
Zhang Y; Lei W; Yan W; Li X; Wang X; Zhao Z; Hui J; Shen Z; Yang J
Stem Cell Res Ther; 2016 Apr; 7(1):61. PubMed ID: 27103465
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-133 overexpression promotes the therapeutic efficacy of mesenchymal stem cells on acute myocardial infarction.
Chen Y; Zhao Y; Chen W; Xie L; Zhao ZA; Yang J; Chen Y; Lei W; Shen Z
Stem Cell Res Ther; 2017 Nov; 8(1):268. PubMed ID: 29178928
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-133a engineered mesenchymal stem cells augment cardiac function and cell survival in the infarct heart.
Dakhlallah D; Zhang J; Yu L; Marsh CB; Angelos MG; Khan M
J Cardiovasc Pharmacol; 2015 Mar; 65(3):241-51. PubMed ID: 25658461
[TBL] [Abstract][Full Text] [Related]
4. microRNA-378 promotes mesenchymal stem cell survival and vascularization under hypoxic-ischemic conditions in vitro.
Xing Y; Hou J; Guo T; Zheng S; Zhou C; Huang H; Chen Y; Sun K; Zhong T; Wang J; Li H; Wang T
Stem Cell Res Ther; 2014 Nov; 5(6):130. PubMed ID: 25418617
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of insulin-like growth factor 1 exerts a protective effect on hypoxic injury of aged BM-MSCs: role of autophagy.
Yang M; Wen T; Chen H; Deng J; Yang C; Zhang Z
Stem Cell Res Ther; 2018 Oct; 9(1):284. PubMed ID: 30359321
[TBL] [Abstract][Full Text] [Related]
6. Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2.
Kim HW; Haider HK; Jiang S; Ashraf M
J Biol Chem; 2009 Nov; 284(48):33161-8. PubMed ID: 19721136
[TBL] [Abstract][Full Text] [Related]
7. Exosomes secreted from GATA-4 overexpressing mesenchymal stem cells serve as a reservoir of anti-apoptotic microRNAs for cardioprotection.
Yu B; Kim HW; Gong M; Wang J; Millard RW; Wang Y; Ashraf M; Xu M
Int J Cardiol; 2015 Mar; 182():349-60. PubMed ID: 25590961
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of inositol hexakisphosphate kinases (IP6Ks) enhances mesenchymal stem cell engraftment and improves therapeutic efficacy for myocardial infarction.
Zhang Z; Liang D; Gao X; Zhao C; Qin X; Xu Y; Su T; Sun D; Li W; Wang H; Liu B; Cao F
Basic Res Cardiol; 2014 Jul; 109(4):417. PubMed ID: 24847908
[TBL] [Abstract][Full Text] [Related]
9. Autophagy mediates the beneficial effect of hypoxic preconditioning on bone marrow mesenchymal stem cells for the therapy of myocardial infarction.
Zhang Z; Yang C; Shen M; Yang M; Jin Z; Ding L; Jiang W; Yang J; Chen H; Cao F; Hu T
Stem Cell Res Ther; 2017 Apr; 8(1):89. PubMed ID: 28420436
[TBL] [Abstract][Full Text] [Related]
10. Hypoxic preconditioning improves the survival and neural effects of transplanted mesenchymal stem cells via CXCL12/CXCR4 signalling in a rat model of cerebral infarction.
Hu Y; Chen W; Wu L; Jiang L; Qin H; Tang N
Cell Biochem Funct; 2019 Oct; 37(7):504-515. PubMed ID: 31368195
[TBL] [Abstract][Full Text] [Related]
11. Pim-1 kinase cooperates with serum signals supporting mesenchymal stem cell propagation.
Zhao Y; Hu J; Buckingham B; Pittenger MF; Wu ZJ; Griffith BP
Cells Tissues Organs; 2014; 199(2-3):140-9. PubMed ID: 25402318
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-140 attenuates myocardial ischemia-reperfusion injury through suppressing mitochondria-mediated apoptosis by targeting YES1.
Yang S; Li H; Chen L
J Cell Biochem; 2019 Mar; 120(3):3813-3821. PubMed ID: 30259997
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of microRNA-214 improves therapeutic potential of allogeneic bone marrow-derived mesenchymal stem cell by targeting PIM-1 in rats with acute liver failure.
Yang J; Li R; Zhao D; Zheng S
J Cell Biochem; 2019 Aug; 120(8):12887-12903. PubMed ID: 30938885
[TBL] [Abstract][Full Text] [Related]
14. Inducible miR-145 expression by HIF-1a protects cardiomyocytes against apoptosis via regulating SGK1 in simulated myocardial infarction hypoxic microenvironment.
Sun N; Meng F; Xue N; Pang G; Wang Q; Ma H
Cardiol J; 2018; 25(2):268-278. PubMed ID: 28980287
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival.
Huang F; Zhu X; Hu XQ; Fang ZF; Tang L; Lu XL; Zhou SH
Int J Mol Med; 2013 Feb; 31(2):484-92. PubMed ID: 23229021
[TBL] [Abstract][Full Text] [Related]
16. C1q tumor necrosis factor-related protein-3 protects mesenchymal stem cells against hypoxia- and serum deprivation-induced apoptosis through the phosphoinositide 3-kinase/Akt pathway.
Hou M; Liu J; Liu F; Liu K; Yu B
Int J Mol Med; 2014 Jan; 33(1):97-104. PubMed ID: 24212403
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of MicroRNA-1 improves the efficacy of mesenchymal stem cell transplantation after myocardial infarction.
Huang F; Li ML; Fang ZF; Hu XQ; Liu QM; Liu ZJ; Tang L; Zhao YS; Zhou SH
Cardiology; 2013; 125(1):18-30. PubMed ID: 23615185
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of miR-17-5p promotes mesenchymal stem cells to repair spinal cord injury.
Yue XH; Guo L; Wang ZY; Jia TH
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3899-3907. PubMed ID: 31115018
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidic acid protects mesenchymal stem cells against hypoxia and serum deprivation-induced apoptosis.
Chen J; Baydoun AR; Xu R; Deng L; Liu X; Zhu W; Shi L; Cong X; Hu S; Chen X
Stem Cells; 2008 Jan; 26(1):135-45. PubMed ID: 17932426
[TBL] [Abstract][Full Text] [Related]
20. Hypoxic Preconditioning Promotes the Bioactivities of Mesenchymal Stem Cells via the HIF-1α-GRP78-Akt Axis.
Lee JH; Yoon YM; Lee SH
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28635661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
